The 2025 GLP-1 guidelines have positioned these drugs at the forefront of type 2 diabetes management, reflecting their multifaceted benefits
Around 10% of the 66 million Medicare beneficiaries are expected to be eligible for the drugs starting next year with new, expanded access
however, the shared genetic variants associated with AUD and BMI had opposing effects [26]
In the present study, by focusing on intestinal L-cells and pancreatic -cells, we discovered the commonalities and differences between insulin and GLP-1 secretions, using GLUTag cells and MIN-6 cells
Hadjyanni et al
Our work includes education to help you navigate treatment, campaigns to fight stigma, programs that empower patients to advocate for themselves, community support networks, and charitable programs for those facing cost barriers